COVID-19: breaking down a global health crisis
Abstract Coronavirus disease 2019 (COVID-19) is the second pandemic of the twenty-first
century, with over one-hundred million infections and over two million deaths to date. It is a …
century, with over one-hundred million infections and over two million deaths to date. It is a …
COVID-19 transmission, current treatment, and future therapeutic strategies
VS Salian, JA Wright, PT Vedell, S Nair… - Molecular …, 2021 - ACS Publications
At the stroke of the New Year 2020, COVID-19, a zoonotic disease that would turn into a
global pandemic, was identified in the Chinese city of Wuhan. Although unique in its …
global pandemic, was identified in the Chinese city of Wuhan. Although unique in its …
[HTML][HTML] Estado actual de los tratamientos para la COVID-19
MN Llover, MC Jiménez - Fmc, 2021 - ncbi.nlm.nih.gov
A finales de 2019 se identificó un nuevo coronavirus como la causa de un grupo de casos
de neumonía en Wuhan, China. Posteriormente, la infección se extendió rápidamente por …
de neumonía en Wuhan, China. Posteriormente, la infección se extendió rápidamente por …
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label …
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
[PDF][PDF] Therapeutics and COVID-19: living guideline, 14 July 2022
World Health Organization - 2022 - apps.who.int
As of May 2022, there have been over 524 million confirmed cases of COVID-19 (10). The
pandemic has thus far claimed approximately 6.2 million lives (10). Vaccination is having a …
pandemic has thus far claimed approximately 6.2 million lives (10). Vaccination is having a …
[HTML][HTML] Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform …
G Reis, EA dos Santos Moreira-Silva… - The Lancet Global …, 2022 - thelancet.com
Background Recent evidence indicates a potential therapeutic role of fluvoxamine for
COVID-19. In the TOGETHER trial for acutely symptomatic patients with COVID-19, we …
COVID-19. In the TOGETHER trial for acutely symptomatic patients with COVID-19, we …
[HTML][HTML] Factores asociados a la automedicación con fármacos relacionados a COVID-19 en estudiantes de ciencias de la salud de una ciudad peruana
A Miñan-Tapia, A Conde-Escobar, D Calderon-Arce… - 2020 - europepmc.org
Objetivos: Determinar los factores asociados a la automedicación con fármacos
relacionados con COVID-19 en estudiantes de ciencias de la salud. Material y métodos …
relacionados con COVID-19 en estudiantes de ciencias de la salud. Material y métodos …
[HTML][HTML] COVID-19-neutralizing antibodies predict disease severity and survival
Summary Coronavirus disease 2019 (COVID-19) exhibits variable symptom severity ranging
from asymptomatic to life-threatening, yet the relationship between severity and the humoral …
from asymptomatic to life-threatening, yet the relationship between severity and the humoral …
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
Importance Evidence regarding corticosteroid use for severe coronavirus disease 2019
(COVID-19) is limited. Objective To determine whether hydrocortisone improves outcome for …
(COVID-19) is limited. Objective To determine whether hydrocortisone improves outcome for …
Effect of early treatment with ivermectin among patients with Covid-19
G Reis, EASM Silva, DCM Silva… - … England Journal of …, 2022 - Mass Medical Soc
Background The efficacy of ivermectin in preventing hospitalization or extended observation
in an emergency setting among outpatients with acutely symptomatic coronavirus disease …
in an emergency setting among outpatients with acutely symptomatic coronavirus disease …